Literature DB >> 22553428

Erythromycin-resistant group G streptococci in an isolated northern Canadian community.

L Nicolle1, B Postl, B Urias, B Law, N Ling, A Efstratiou.   

Abstract

The susceptibility of groups A, C, and G streptococci isolated from pharynx or skin in two northern Canadian native communities during a one year study of the epidemiology of streptococcal infection was determined for penicillin, erythromycin and clindamycin using an agar dilution method. Organisms studied included 725 group A, 82 group C, and 184 group G streptococci. All organisms were susceptible to penicillin (minimum inhibitory concentration [MIC] range less than 0.004 to 0.015 μg/mL; MIC(90) 0.015 μg/mL) and clindamycin (range 0.007 to 0.06 μg/mL; MIC(90) 0.06 μg/mL) with no differences observed between streptococcal groups. For erythromycin, groups A and C were generally susceptible (range less than 0.007 to 0.030 μg/mL; MIC(90) 0.03 μg/mL; and range 0.007 to 1.0 μg/mL; MIC(90) 0.06 μg/mL, respectively). Group G was less susceptible (range 0.007 to greater than 2.0 μg/mL; MIC(90) greater than 2.0 μg/mL) with 38% of all isolates having an MIC greater than or equal to 1 μg/mL. On review of group G isolates, 100 of 100 from one community were susceptible (MIC less than 0.007 to 0.03 μg/mL) and 73 (87%) of 84 from the second community were resistant. All resistant strains tested were type T16. These data suggest that erythromycin-resistant group G streptococci may occur with high prevalence in certain populations and that patterns of antimicrobial susceptibility in isolated communities may be highly community-specific.

Entities:  

Keywords:  Antimicrobial resistance; Erythromycin; Group G streptococci; Native health

Year:  1990        PMID: 22553428      PMCID: PMC3327957          DOI: 10.1155/1990/808271

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  12 in total

1.  Group A streptococcal pharyngeal carriage, pharyngitis, and impetigo in two northern Canadian native communities.

Authors:  L E Nicolle; B Postl; B Urias; B Law; N Ling
Journal:  Clin Invest Med       Date:  1990-06       Impact factor: 0.825

Review 2.  Group G streptococcal infections.

Authors:  P N Gaunt; D V Seal
Journal:  J Infect       Date:  1987-07       Impact factor: 6.072

3.  Conjugative R plasmids in group C and G streptococci.

Authors:  L Bougueleret; G Bieth; T Horodniceanu
Journal:  J Bacteriol       Date:  1981-02       Impact factor: 3.490

4.  Serious infections due to group G streptoccocci. Report of 15 cases with in vitro-in vivo correlations.

Authors:  K Lam; A S Bayer
Journal:  Am J Med       Date:  1983-10       Impact factor: 4.965

5.  The serotyping of hospital strains of streptococci belonging to Lancefield group C and group G.

Authors:  A Efstratiou
Journal:  J Hyg (Lond)       Date:  1983-02

6.  In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.

Authors:  G M Eliopoulos; A Gardella; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

7.  Emergence of rifampin-resistant Haemophilus influenzae.

Authors:  L E Nicolle; B Postl; E Kotelewetz; W Albritton; G K Harding; A M Bourgault; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

8.  Antimicrobial tolerance in group C and group G streptococci.

Authors:  K V Rolston; P H Chandrasekar; J L LeFrock
Journal:  J Antimicrob Chemother       Date:  1984-04       Impact factor: 5.790

9.  Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan.

Authors:  S Maruyama; H Yoshioka; K Fujita; M Takimoto; Y Satake
Journal:  Am J Dis Child       Date:  1979-11

10.  Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin.

Authors:  G R Istre; D F Welch; M I Marks; N Moyer
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.